These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33035579)

  • 1. Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats.
    Naserifar M; Hosseinzadeh H; Abnous K; Mohammadi M; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Dec; 262():118555. PubMed ID: 33035579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exosomal approach for oral delivery of resveratrol: Implications for inflammatory bowel disease treatment in rat model.
    Esfahani SK; Dehghani S; Hosseinzadeh H; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2024 Jun; 346():122638. PubMed ID: 38614294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells.
    Senthil Kumar C; Thangam R; Mary SA; Kannan PR; Arun G; Madhan B
    Carbohydr Polym; 2020 Mar; 231():115682. PubMed ID: 31888816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
    Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
    Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
    Xin Y; Liu T; Yang C
    Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol.
    Prezotti FG; Boni FI; Ferreira NN; Silva DS; Almeida A; Vasconcelos T; Sarmento B; Gremião MPD; Cury BSF
    Drug Dev Ind Pharm; 2020 Feb; 46(2):236-245. PubMed ID: 31928345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol-loaded folate targeted lipoprotein-mimetic nanoparticles with improved cytotoxicity, antioxidant activity and pharmacokinetic profile.
    Poonia N; Lather V; Narang JK; Beg S; Pandita D
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111016. PubMed ID: 32993976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted folate-conjugated pluronic P85/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin.
    Xie S; Gong YC; Xiong XY; Li ZL; Luo YY; Li YP
    Nanomedicine (Lond); 2018 Oct; 13(19):2527-2544. PubMed ID: 30338724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
    Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
    J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
    Siu FY; Ye S; Lin H; Li S
    Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
    Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient controlled release strategy for hypertension therapy: Folate-mediated lipid nanoparticles for oral peptide delivery.
    Li J; Chen B; Yu T; Guo M; Zhao S; Zhang Y; Jin C; Peng X; Zeng J; Yang J; Song X
    Pharmacol Res; 2020 Jul; 157():104796. PubMed ID: 32278048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.
    Helmy SA; El-Mofty S; El Gayar AM; El-Sherbiny IM; El-Far YM
    Biomed Pharmacother; 2022 Jan; 145():112376. PubMed ID: 34749055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
    Ali H; Weigmann B; Neurath MF; Collnot EM; Windbergs M; Lehr CM
    J Control Release; 2014 Jun; 183():167-77. PubMed ID: 24685705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction.
    Sun L; Hu Y; Mishra A; Sreeharsha N; Moktan JB; Kumar P; Wang L
    Biofactors; 2020 May; 46(3):421-431. PubMed ID: 31926035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
    Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
    Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
    Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.